The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.
Benichou
G
G
Department of Surgery, ITL, University of California San Francisco School of Medicine 94143-0508, USA.
Tam
R C
RC
Soares
L R
LR
Popov
I A
IA
Garovoy
M R
MR
Fedoseyeva
E V
EV
D000818:Animals; D017951:Antigen Presentation; D006084:Graft Rejection / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007519:Isoantigens / Q000276:immunology*; D008285:Major Histocompatibility Complex; D010455:Peptides / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology
D006649:Histocompatibility Antigens; D007519:Isoantigens; D010455:Peptides